£2.16m
+647%vs Oct 2024Active09901425Private limited companyFareham
INVITRO GENETICS LIMITED
Significant control: Coopersurgical Holdings Limited (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Invitro Genetics Limited sell?
Registered activity: Specialists medical practice activities (SIC 86220). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
INVITRO GENETICS LIMITED is an active private limited company (company number 09901425) incorporated on 3 December 2015, registered in Fareham. Its registered activity is specialists medical practice activities (SIC 86220). Latest full accounts cover the period ending 31 October 2025, showing net assets of £2.16m and cash of £695k, with 24 employees on average. Turnover was £8.95m and profit for the year £1.87m. Net assets rose 647% on the prior period (£289k).
Peer position · net assets
By net assets it sits in the top quarter of 217 comparable companies in Portsmouth (median £31k, upper quartile £111k).
02
Ownership and control
- Coopersurgical Holdings Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 3 December 201510 yrs ago
- Next accounts due
- 31 July 2027in 281 days
- Confirmation statement due
- 17 December 2026in 55 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 86220
- Specialists medical practice activities
- Accounts type
- Full
- Size band
- SmallCompanies Act thresholds
05
Financials
£695k
+31%vs Oct 2024£8.95m
+20%vs Oct 202424
−11%vs Oct 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 October 2025 | £2.16m | £695k | £1.52m | £1.96m | £8.95m | £1.87m | 24 |
| 31 October 2024 | £289k | £530k | £1.31m | £3.00m | £7.47m | £278k | 27 |
| 31 October 2023 | — | — | — | — | — | — | — |
Current ratio1.41Current assets ÷ creditors within one year
Net margin20.9%Profit for the year ÷ turnover
Cash per employee£29kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £2,158,534 at 31 October 2025
- Net assets up 10% or more on the prior period+647.3% vs prior period
- Cash at bank of £50,000 or moreCash £695,477
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 3 December 2015
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 281 days
- Confirmation statement duein 55 days
- Accounts period endNet assets £2.16m · full accounts
- Accounts period endNet assets £289k · full accounts
- Accounts period end
- Incorporated
08
Similar companies in Portsmouth
- MAQBOOL JAFFER LIMITEDPortsmouth · inc. Dec 2015
- P1 SPORTS PERFORMANCE LTDPortsmouth · inc. Jan 2016
- THE MAITLAND CLINIC LIMITEDDenmead · inc. Oct 2015
- RUNCTON PATHOLOGY LIMITEDChichester · inc. Mar 2016
- BEACON SLS LTDNewport · inc. Mar 2016
- SOUTHERN ORTHOTICS SOLUTIONS LIMITEDSouthsea · inc. Apr 2016
All companies incorporated on 3 December 2015 · in Dec 2015.
09
Reminders for INVITRO GENETICS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.